Mydecine Innovations Group Inc.
MYCOF
Price:
$0.0042
Market Cap:
$150.65K
Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. It develops therapies for veterans, emergency medical service providers, post-traumatic stress disorder, and front-line workers; and operates Mindleap, a digital telehealth platform that provides access to mental health services, as well as psychedelic integration services, including psychedelic aftercare and wellness services. The company also engages in the drug discovery and builds nature-sourced psychedelic-assisted therapeutics, compounds, therapy protocols, and unique delivery systems. In addition, it operates hemp farm in ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
MYCOF
The ROE as of September 2024 (TTM) for Mydecine Innovations Group Inc. (MYCOF) is 206.18%
According to Mydecine Innovations Group Inc.’s latest financial reports and current stock price. The company's current ROE is 206.18%. This represents a change of 198.67% compared to the average of 69.03% of the last 4 quarters.
Mydecine Innovations Group Inc. (MYCOF) Historical ROE (quarterly & annually)
How has MYCOF ROE performed in the past?
The mean historical ROE of Mydecine Innovations Group Inc. over the last ten years is -1453.54%. The current 206.18% ROE has changed -114.18% with respect to the historical average. Over the past ten years (40 quarters), MYCOF's ROE was at its highest in in the December 2015 quarter at 739.45%. The ROE was at its lowest in in the December 2021 quarter at -5149.18%.
Average
-1453.54%
Median
-485.49%
Minimum
-13590.72%
Maximum
3.05%
Mydecine Innovations Group Inc. (MYCOF) ROE by Quarter and Year
Discovering the peaks and valleys of Mydecine Innovations Group Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.38%
Maximum Annual ROE = 3.05%
Minimum Annual Increase = -331.14%
Minimum Annual ROE = -13590.72%
| Year | ROE | Change |
|---|---|---|
| 2023 | 175.80% | -46.59% |
| 2022 | 329.14% | -102.42% |
| 2021 | -13590.72% | 1.66% |
| 2020 | -773.92% | 1.98% |
| 2019 | -37.14% | -90.65% |
| 2018 | -397.10% | -71.64% |
| 2017 | -1400.30% | 144.01% |
| 2016 | -573.87% | -118.79% |
| 2015 | 3.05% | -331.14% |
| 2014 | -1321.28% | 11.38% |
Mydecine Innovations Group Inc. (MYCOF) Average ROE
How has MYCOF ROE performed in the past?
The current ROE of Mydecine Innovations Group Inc. (MYCOF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4361.93%
5-year avg
-2779.37%
10-year avg
-1453.54%
Mydecine Innovations Group Inc. (MYCOF) ROE vs. Peers
How is MYCOF’s ROE compared to its peers?
Mydecine Innovations Group Inc.’s ROE is less than Green Cures & Botanical Distribution Inc. (89.83%), greater than Cann American Corp. (-80.83%), less than Rimrock Gold Corp. (8.44%), greater than Galexxy Holdings, Inc. (-28.29%), less than Indoor Harvest Corp (1.34%), less than CBD Global Sciences Inc. (105.36%), greater than MGC Pharmaceuticals Limited (-146.51%), greater than Target Group Inc. (1.00%), less than Aequus Pharmaceuticals Inc. (62.13%), greater than Filament Health Corp. (-178.95%), less than Aleafia Health Inc. (965.68%), less than Pharmagreen Biotech Inc. (18.07%), less than Endexx Corporation (22.78%), greater than Green Growth Brands Inc. (-311.96%), less than HempAmericana, Inc (0%), greater than Radient Technologies Inc. (0%), greater than Nextleaf Solutions Ltd. (0%), greater than Abattis Bioceuticals Corp. (-18.36%), greater than null (-26.96%),
| Company | ROE | Market cap |
|---|---|---|
| 89.83% | $783.95K | |
| -80.83% | $1.33M | |
| 8.44% | $234.23K | |
| -28.29% | $5.16M | |
| 1.34% | $320.57K | |
| 105.36% | $2.07M | |
| -146.51% | $12.11M | |
| 1.00% | $1.23M | |
| 62.13% | $1.99M | |
| -178.95% | $9.30M | |
| 965.68% | $6.09M | |
| 18.07% | $1.79M | |
| 22.78% | $6.03M | |
| -311.96% | $2.06K | |
| 0% | $291.75K | |
| 0% | $197.82M | |
| 0% | $9.78M | |
| -18.36% | $47.60K | |
| -26.96% | $0 |
Build a custom stock screener for Mydecine Innovations Group Inc. (MYCOF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mydecine Innovations Group Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Mydecine Innovations Group Inc. (MYCOF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Mydecine Innovations Group Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Mydecine Innovations Group Inc.'s ROE?
How is the ROE calculated for Mydecine Innovations Group Inc. (MYCOF)?
What is the highest ROE for Mydecine Innovations Group Inc. (MYCOF)?
What is the 3-year average ROE for Mydecine Innovations Group Inc. (MYCOF)?
What is the 5-year average ROE for Mydecine Innovations Group Inc. (MYCOF)?
How does the current ROE for Mydecine Innovations Group Inc. (MYCOF) compare to its historical average?